RecruitingNot ApplicableNCT05205980

Perturbation Training Reduces Falls in People With Alzheimer's Disease (AD)

Motor Learning of Fall Resistant Skills From Laboratory-induced Falling Among People With Mild Alzheimer's Disease


Sponsor

Georgia State University

Enrollment

30 participants

Start Date

Apr 28, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This study will examine the overall capacity of people with Alzheimer's disease learning fall-resistant skills from perturbation training.


Eligibility

Min Age: 65 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a specialized balance training program using unexpected surface movements (called perturbation training — where the floor briefly shifts under your feet to challenge your balance) can reduce falls in people with Alzheimer's disease. **You may be eligible if...** - You are 65 or older - You have a clinical diagnosis of probable Alzheimer's disease - You can read and understand English - You can walk at least 25 feet independently - You can stand without support for at least 30 seconds - Your cognitive test scores fall in a specific range (moderate impairment) **You may NOT be eligible if...** - You have previously done perturbation balance training - You have uncontrolled blood pressure (too high or too low) - You have a bone or joint condition that prevents balance training - You have a neurological condition other than Alzheimer's affecting your balance Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALPerturbation training

Participants will experience repeated perturbations mixed with non-perturbed trials on the treadmill with the protection by a harness.


Locations(1)

Reminiscent

Valdosta, Georgia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05205980


Related Trials